Orthofix Medical

Orthofix Medical EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Orthofix Medical (OFIX) as of Oct 30, 2026 is -476.30. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -68.48 — a change of 595.54% (lower).

EV/FCF

-476.30

YoY

595.54%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Orthofix Medical is 2025 -476.30 . EV/FCF (Enterprise Value to Free Cash Flow) of Orthofix Medical was 2024 -68.48 . It decreases by 595.54% lower compared to the previous year.

The Orthofix Medical EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
13.28 USD
Jan 1, 2019
41.80 USD
Jan 1, 2020
7.98 USD
Jan 1, 2021
-415.84 USD
Jan 1, 2022
-14.38 USD
Jan 1, 2023
-5.66 USD
Jan 1, 2024
-68.48 USD
Jan 1, 2025
-476.30 USD
The Orthofix Medical EV/FCF history
YEAREV/FCFYoY
-476.30+595.54%
-68.48+1,109.56%
-5.66-60.64%
-14.38-96.54%
-415.84-5,310.24%
7.98-80.91%
41.80+214.85%
13.28+7.69%
12.33-33.68%
18.59-38.89%
30.42+100.11%
15.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Orthofix Medical Stock analysis

What does Orthofix Medical do? Orthofix Medical Inc is a leading global company in the field of orthopedic medical devices. The company is headquartered in Lewisville, Texas, USA and has been publicly traded since 1987. Orthofix's history dates back to the 1970s when it was founded as a small startup company. Since then, it has grown into a multinational company employing several thousand employees worldwide. Orthofix's business model is based on developing, manufacturing, and distributing orthopedic products and services that contribute to the restoration of mobility and quality of life for people with orthopedic conditions and injuries. The company offers a wide range of products ranging from implantable medical devices to conservative therapy options. Orthofix operates in three main divisions: 1. Spinal Implants and Biologics: This includes products such as intervertebral disc implants, interactive spinal fracture systems, and biological products to support bone healing. 2. Extremity Fixation: In this area, the company offers various implants for stabilizing fractures and joints, such as wrist supports or nail implants for stabilizing bone fractures in the arms and legs. 3. Orthofix PhysioStim: Orthofix PhysioStim is a non-invasive therapy option that supports bone and soft tissue healing. It is a portable device that generates electrical impulses and is used over an extended period of time. Orthofix's broad product portfolio also includes specialized products and services tailored to specific medical needs and groups. For example, the company offers some products specifically for children, such as the Pediatric Locking Nail System, a nail system for treating forearm and leg fractures in children. The company also provides products for animals, such as the VetLok External Fixation System, an implant system for stabilizing bone fractures in animals. Orthofix is committed to quality and product innovation to meet the needs of its customers and differentiate itself in a highly competitive market. The company continuously invests in research and development to develop new technologies and products that contribute to improving patient outcomes and support the work of doctors and surgeons. Overall, Orthofix Medical Inc is a leading company in the field of orthopedic medical devices, offering a wide range of products and services to support patients in restoring their mobility and quality of life. The company is committed to quality, innovation, and customer satisfaction, and invests in research and development to play a leading role in a competitive market. Orthofix Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orthofix Medical stock

EV/FCF (Enterprise Value to Free Cash Flow) of Orthofix Medical is -476.30 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Orthofix Medical changed from -68.48 to -476.30, representing a 595.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Orthofix Medical since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Orthofix Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Orthofix Medical

All Key Metrics — Orthofix Medical